Fol. Biol. 2016, 62, 1-14
https://doi.org/10.14712/fb2016062010001
Proliferative Capacity and Phenotypical Alteration of Multipotent Ecto-Mesenchymal Stem Cells from Human Exfoliated Deciduous Teeth Cultured in Xenogeneic and Allogeneic Media
References
1. 2014) Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes. Stem Cell Rev. Rep. 10, 327-337.
< , E. M. (https://doi.org/10.1007/s12015-014-9503-6>
2. 2008) Mesenchymal stem cells from different organs are characterized by distinct topographic Hox codes. Stem Cells Dev. 17, 979-992.
< , K. B., Charité, J. (https://doi.org/10.1089/scd.2007.0220>
3. Akpinar, G., Kasap, M., Aksoy, A., Duruksu, G., Gacar, G., Karaoz, E. (2014) Phenotypic and proteomic characteristics of human dental pulp derived mesenchymal stem cells from a natal, an exfoliated deciduous, and an impacted third molar tooth. Stem Cells Int. 2014.
4. 2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J. Cell. Physiol. 211, 121-130.
< , M. E., Avanzini, M. A., Perotti, C., Cometa, A. M., Moretta, A., Lenta, E., Del Fante, C., Novara, F., de Silvestri, A., Amendola, G., Zuffardi, O., Maccario, R., Locatelli, F. (https://doi.org/10.1002/jcp.20911>
5. Bieback, K., Ha, V. A., Hecker A., Grassl, M., Kinzebach, S., Solz, H., Sticht, C., Kluter, H., Bugert, P. (2010) Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. See comment in PubMed Commons belowTissue Eng. Part A. 16, 3467-3484.
6. 2004) Effects of serum and serum heat-inactivation on human bone derived osteoblast progenitor cells. J. Mater. Sci. Mater. Med. 15, 497-501.
< , A., Tobler, U., Halg, M., Grűnert, J. (https://doi.org/10.1023/B:JMSM.0000021127.62879.a1>
7. 2010) Serum-free cell culture: the serum- free media interactive online database. ALTEX 27, 53.
< , D., Frank, J., Appl, H., Schöffl, H., Pfaller, W., Gstraunthaler, G. (https://doi.org/10.14573/altex.2010.1.53>
8. 1991) Mesenchymal stem cells. J. Orthop. Res. 9, 641-650.
< , A. I. (https://doi.org/10.1002/jor.1100090504>
9. 2004) Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol. 95, 29-33.
< , J. C., Herreros, J., Trainini, J., Juffe, A., Rendal, E., Prosper, F., Genovese, J. (https://doi.org/10.1016/S0167-5273(04)90009-5>
10. 2012) The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars. Biomaterials 33, 5023-5035.
< , B., Sun, H., Wang, H., Kong, H., Chen, F., Yu, Q. (https://doi.org/10.1016/j.biomaterials.2012.03.057>
11. 2007) Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J. Neurosci. Methods 161, 250-258.
< , C., Tronnier, V., Unterberg, A., Herold-Mende, C. (https://doi.org/10.1016/j.jneumeth.2006.11.012>
12. 2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24, 1407-1408.
< , I., Levicar, N. (https://doi.org/10.1634/stemcells.2005-0577>
13. 2006a) A second generation platelet concentrate: Part I: Technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, e37-44.
< , D. M., Choukroun, J., Diss, A., Dohan, S. L. Dohan, A. J. J., Mouhyi, J., Gogly, B. (https://doi.org/10.1016/j.tripleo.2005.07.008>
14. 2006b) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, e45-50.
< , D. M., Choukroun, J., Diss, A., Dohan, S. L. Dohan, A. J. J., Mouhyi, J., Gogly, B. (https://doi.org/10.1016/j.tripleo.2005.07.009>
15. 2006c) Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: a new feature for platelet concentrates? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, e51-55.
< , D. M., Choukroun, J., Diss, A., Dohan, S. L. Dohan, A. J. J., Mouhyi, J., Gogly, B. (https://doi.org/10.1016/j.tripleo.2005.07.010>
16. 2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
< , M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Horwitz, E. M. (https://doi.org/10.1080/14653240600855905>
17. 1999) The development, benefits and disadvantages of serum-free media. Dev. Biol. Stand. 99, 157-166.
, S. J. (
18. 2011) Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications. Cytotherapy 13, 1221-1233.
< , V., Ronald, V. S., Abdullah, A. N. B., Nathan, K. R. G., Aziz, Z. A. Ch. A., Abdullah, M., Zain, R. B., Kasim, N. H. A., Musa, S., Bhonde, R. R. (https://doi.org/10.3109/14653249.2011.602337>
19. 2002) Stem cell properties of human dental pulp stem cells. J. Den. Res. 81, 531-535.
< , S., Brahim, J., Li, W., Fisher, L. W., Cherman, N., Boyde, A., Shi, S. (https://doi.org/10.1177/154405910208100806>
20. 2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 97, 13625-13630.
< , S., Mankani, M., Brahim, J., Robey, P. G., Shi, S. (https://doi.org/10.1073/pnas.240309797>
21. 2014) Human platelet lysates successfully replace fetal bovine serum in adipose-derived adult stem cell culture. J. Adv. Biotech. Bioeng. 10, 1-11.
< , G., Rauch, C., Wechselberger, J., Feifel, E. (https://doi.org/10.12970/2311-1755.2014.02.01.1>
22. 2006) FDA regulation of stemcell- based therapies. New Engl. J. Med. 355, 1730-1735.
< , D. G., Kessler, D. A. (https://doi.org/10.1056/NEJMhpr063086>
23. 2013) Stem cells in the context of evolution and development. Dev. Genes Evol. 223, 1-3.
< , V. (https://doi.org/10.1007/s00427-012-0430-8>
24. 1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
< , L. (https://doi.org/10.1016/0014-4827(65)90211-9>
25. 2007) N-Glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25, 197-202.
< , A., Satomaa, T., Tiitinen, S., Laitinen, A., Mannelin, S., Impola, U., Mikkola, M., Olsson, C., Miller-Podraza, H., Blomqvist, M., Olonen, A., Salo, H., Lehenkari, P., Tuuri, T., Otonkoski, T., Natunen, J., Saarinen, J., Laine, J. (https://doi.org/10.1634/stemcells.2006-0444>
26. 1975) Fetal bovine serum: a multivariate standard. Proc. Soc. Exp. Biol. Med. 149, 344-347.
< , K. V., Singley, J. A., Chavin, W. (https://doi.org/10.3181/00379727-149-38804>
27. 2009) Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J. Dent. Res. 88, 792-806.
< , G. J., Gronthos, S., Shi, S. (https://doi.org/10.1177/0022034509340867>
28. 2007) Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng. 13, 767-773.
< , Y. Y., Lee, H. J., Kook, S. Y., Choung, H. W., Park, J. Y., Chung, J. H., Choung, Y. H., Kim, E. S., Yang H. Ch., Choung, P. H. (https://doi.org/10.1089/ten.2006.0192>
29. 2005) Platelet-rich plasma enhances human osteoblast- like cell proliferation and differentiation. J. Oral Maxillofac. Surg. 63, 362-369.
< , T., Takahashi, T., Tsujisawa, T., Ariyoshi, W., Nishihara, T. (https://doi.org/10.1016/j.joms.2004.07.016>
30. 2011) Characterization of dental pulp stem cells from impacted third molars cultured in low serumcontaining medium. Cells Tissues Organs 193, 344-365.
< , J., Soukup, T., Suchánek, J., Pytlík, R., Corbeil, D., Mokrý, J. (https://doi.org/10.1159/000321160>
31. 2011) Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 20, 1549-1561.
< , O., Mahaira, L. G., Iliopoulou, E. G., Moustaki, A., Antsaklis, A., Loutradis, D., Stefanidis, K., Baxevanis, C. N., Papamichail, M., Perez, S. A. (https://doi.org/10.1089/scd.2010.0280>
32. 2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10, 709-716.
< , A. (https://doi.org/10.1016/j.stem.2012.05.015>
33. 2006) Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs 184, 105-116.
< , I., Kerkis, A., Dozortsev, D. Stukart-Parsons, G. C., Gomes Massironi, S. M., Pereira, L. V., Caplan, A. I., Cerruti, H. F. (https://doi.org/10.1159/000099617>
34. 2004) Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur. J. Med. Res. 9, 337-344.
, O., Flesch, I., Wenisch, S., Taborski, B., Jork, A., Schnettler, R., Jonuleit, T. (
35. 2008) Mechanisms of asymmetric stem cell division. Cell 132, 583-597.
< , J. A. (https://doi.org/10.1016/j.cell.2008.02.007>
36. 2005) Motility and growth of human bone-marrow mesenchymal stem cells during ex-vivo expansion in autologous serum. J. Bone Joint Surg. Br. 87, 1426-1433.
< , T., Watanabe, H., Yanagawa, T., Tsutsumi, S., Kayakabe, M., Shinozaki, T., Higuchi, K., Takagishi, K. (https://doi.org/10.1302/0301-620X.87B10.16160>
37. 2007) Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cell, 25, 1270-1278.
< , A., Kern, S., Klueter, H., Bieback, K. (https://doi.org/10.1634/stemcells.2006-0627>
38. 2013) Exosomes for drug delivery – a novel application for the mesenchymal stem cell. Biotechnol. Adv. 31, 543-551.
< , R. C., Yeo, R. W. Y., Tan, K. H., Lim, S. K. (https://doi.org/10.1016/j.biotechadv.2012.08.008>
39. 2011) Effect of platelet-rich plasma on dental stem cells derived from human impacted third molars. Regen. Med. 6, 67-79.
< , U. L., Jeon, S. H., Park, J. Y., Choung, P. H. (https://doi.org/10.2217/rme.10.96>
40. 2005) Using human plasma supplemented medium to cultivated human bone marrow-derived mesenchymal stem cell and evaluation of its multiple-lineage potential. Transplant. Proc. 37, 4504–4505.
< , H. T., Tarng, Y. W., Chen, Y. C., Kao, C. L., Hsu, C. J., Shyr, Y. M., Ku, H. H., Chiou, S. H. (https://doi.org/10.1016/j.transproceed.2005.11.033>
41. 2014) The capacity of neural crest-derived stem cells for ocular repair. Birth Defects Res. C 102, 299-308.
< , B., Hunter, D. J., Smith, A. A., Chen, S., Helms, J. A. (https://doi.org/10.1002/bdrc.21077>
42. 2003) Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24, 3095-3100.
< , E., Beccheroni, A., Donati, D., Sangiorgi, L., Cenacchi, A., Del Vento, A. M., Meotti, C., Bertoja, A. Z., Giardino, R., Fornasari, P. M., Mercuri, M., Picci, P. (https://doi.org/10.1016/S0142-9612(03)00114-5>
43. 2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25, 1603-1609.
< , F., Tonti, G. A. (https://doi.org/10.1634/stemcells.2007-0127>
44. 2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232.
< , M. J., Muotri, A., Gage, F., Varki, A. (https://doi.org/10.1038/nm1181>
45. 2001). Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant. Dent. 10, 225-228.
< , R. E. (https://doi.org/10.1097/00008505-200110000-00002>
46. 2010) Comparison of human dental follicle cells (DFCs) and stem cells from human exfoliated deciduous teeth (SHED) after neural differentiation in vitro. Clin. Oral Investig. 4, 433-440.
< , C., Völlner, F., Saugspier, M., Brandl, C., Reichert, T. E. Driemel, O., Schmalz, G. (https://doi.org/10.1007/s00784-009-0310-4>
47. 2009). Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng. Part C Methods 15, 431-435.
< , A., Tummala, P., King, A., Lee, B., Kraus, M., Tse, V., Jacobs, C. R. (https://doi.org/10.1089/ten.tec.2008.0534>
48. 2003) SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA 100, 5807-5812.
< , M., Gronthos, S., Zhao, M., Lu, B., Fisher, L. W., Robey, P. G., Shi, S. (https://doi.org/10.1073/pnas.0937635100>
49. 2006). Human autologous serum obtained using a completely closed bag system as a substitute for foetal calf serum in human mesenchymal stem cell cultures. Cell Biol. Int. 30, 521-524.
< , N., Shiba, H., Ozeki, Y., Mouri, Y., Niitani, M., Inui, T., Hayashi, H., Suzuki, K., Tanaka, S., Kawaguchi, H., Kurihara, H. (https://doi.org/10.1016/j.cellbi.2006.01.010>
50. 2013) Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy 15, 1458-1468.
< , M. P., Jacobson, P., Morris, J., Kelley, L., Pierce, J., Boyer, M., Reems, J. A. (https://doi.org/10.1016/j.jcyt.2013.06.014>
51. 2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8, 437-444.
< , I., Kordowich, S., Holzwarth, C., Spano, C., Isensee, G., Staiber, A., Viebahn, S., Gieseke, F., Langer, H., Gawaz, M. P., Horwitz, E. M., Conte, P., Handgretinger, R., Dominici, M. (https://doi.org/10.1080/14653240600920782>
52. Nardi, N. B., da Silva Meirelles, L. (2006) Mesenchymal stem cells: isolation, in vitro expansion and characterization. In: Stem Cells, pp. 249-282, Springer Berlin Heidelberg.
53. 2011) Induced in vitro differentiation of neural-like cells from human exfoliated deciduous teeth-derived stem cells. Int. J. Dev. Biol. 55, 189-195.
< , N., Soleimani, M., Taghipour, Z., Karbalaie, K., Mousavi, S., Talebi, A., Nadali, F., Tanhaei, S., Kiyani, G. A., Nematollahi, M., Rabiei, F., Mardani, M., Bahramiyan, H., Torabinejad, M., Nasr-Esfahani, M. H., Baharvand, H. (https://doi.org/10.1387/ijdb.103090nn>
54. 2013) In vitro pharmacological characterization of a novel TRPA1 antagonist and proof of mechanism in a human dental pulp model. J. Pain Res. 6, 59.
< , E., Franzén, B., Nolting, A., Klement, G., Liu, G., Nilsson, M., Rosén, A., Björk, C., Weigelt, D., Wollberg, P., Karila, P., Raboisson, P. (https://doi.org/10.2147/JPR.S37567>
55. 2010) Human breast milk is a rich source of multipotent mesenchymal stem cells. Human Cell 23, 35-40.
< , S., Kadam, S., Chandra, V., Bhonde, R. (https://doi.org/10.1111/j.1749-0774.2010.00083.x>
56. 2015) Human dental pulp stem cells: Applications in future regenerative medicine. World J. Stem Cells 7, 839-851.
< , P. D., Jethmalani, Y. D. (https://doi.org/10.4252/wjsc.v7.i5.839>
57. 2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220-229.
< , R., Lickorish, D., Baksh, D., Hosseini, M. M., Davies, J. E. (https://doi.org/10.1634/stemcells.2004-0166>
58. 2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530-541.
< , I., Larson, B. L., Smith, J. R., Pochampally, R., Cui, J. G., Prockop, D. J. (https://doi.org/10.1634/stemcells.20-6-530>
59. 2012) Recruitment of dental pulp cells by dentine and pulp extracellular matrix components. Exp. Cell Res. 318, 2397-2406.
< , J. G., Smith, A. J., Shelton, R. M., Cooper, P. R. (https://doi.org/10.1016/j.yexcr.2012.07.008>
60. 2005) In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23, 1357-1366.
< , A., Fronsdal, K., Haug, T., Reinholt, F. P., Brinchmann, J. E. (https://doi.org/10.1634/stemcells.2005-0094>
61. 2005) Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells 23, 1012-1020.
< , D. T. B., Lee, D. C., Chen, S. C., Tsai, R. Y., Huang, C. T., Tsai, C. C., Shen, E.Y., Chiu, W. T. (https://doi.org/10.1634/stemcells.2004-0125>
62. 2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9, 747-756.
< , J. L., Gregory, C. A., Singh, H., Tucker, H. A., Peister, A., Lynch, P. J., Hsu, S. Ch., Smith, J., Prockop, D. J. (https://doi.org/10.1016/j.ymthe.2004.02.012>
63. 2005) Humanserum matrix supports undifferentiated growth of human embryonic stem cells. Stem Cells 23, 895-902.
< , P., Lako, M., Przyborski, S., Stewart, R., Armstrong, L., Evans, J., Zhang. X., Stojkovic, M. (https://doi.org/10.1634/stemcells.2004-0326>
64. 2004) Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp. Hematol. 32, 1212-1225.
< , N., Holtz, K., Bubenheim, M., Lange, C., Blake, F., Zander, A. R. (https://doi.org/10.1016/j.exphem.2004.09.003>
65. 2009) Dental pulp stem cells and their characterization Biomed Pap. Med. Fac. Univ. Palacky Olomouc, Czech Repub. 153, 31-35.
< , J., Soukup, T., Víšek, B., Ivančaková, R., Kučerová, L., Mokrý, J. (https://doi.org/10.5507/bp.2009.005>
66. 2013) The effect of fetal calf serum on human dental pulp stem cells. Acta Medica (Hradec Kralove), 56, 142-149.
< , J., Suchánková Kleplová, T., Kapitán, M., Soukup, T. (https://doi.org/10.14712/18059694.2014.9>
67. 2002) Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum. Gene Ther. 13, 1605-1610.
< , L., Soenen, S. L., Blaese, R. M., Candotti, F., Muul, L. M. (https://doi.org/10.1089/10430340260201699>
68. 2006). The heterogeneity of human mesenchymal stem cell preparations – evidence from simultaneous analysis of proteomes and transcriptomes. Exp. Hematol. 34, 536-548.
< , W., Feldmann, R. E., Seckinger, A., Maurer, M. H., Wein, F., Blake, J., Krause, U., Kalenka, A., Bürgers, H. F., Saffrich, R., Wuchter, P., Kuschinsky, W., Ho, A. D. (https://doi.org/10.1016/j.exphem.2006.01.002>
69. Weyand, B., Dominici, M., Hass, R., Jacobs, R., Kasper, C. (2013). Mesenchymal Stem Cells – Basics and Clinical Application II. Springer Berlin.
70. 1997) Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting. Bull. World Health Organ. 75, 505-513.
(
71. 2011) Promising cell-based therapy for bone regeneration using stem cells from deciduous teeth, dental pulp, and bone marrow. Cell. Transplant. 20, 1003-1013.
< , Y., Ito, K., Nakanuta, S., Ueda, M., Nagasaki, T. (https://doi.org/10.3727/096368910X539128>
72. Zhang, Q., Sun, X., Ding, J., He, P., Liu, Y., Cheng, H., Zhou, Ch., Meng, X. (2015). Autoserum: an optimal supplement for bone marrow mesenchymal stem cells of liver-injured rats. Stem Cells Int. 2015.
73. 2006). Multilineage differentiation potential of stem cells derived from human dental pulp after cryopreservation. Tissue Eng. 12, 2813-2823.
< , W., Walboomers, X. F., Shi, S., Fan, M., Jansen, J. A. (https://doi.org/10.1089/ten.2006.12.2813>